Abbott Seeks FDA approval for cancer drug despite failed trials – WSJ Mon, 12 Sep 2005 Abbott Laboratories is asking the FDA to approve a cancer drug even though it failed in clinical trials to demonstrate a benefit greater than placebo–which is a minimal FDA requirement. The Wall Street Journal…
FDA Had Report of Heart Device failures Mon, 12 Sep 2005 A series of irresponsible national policies put corporate interests above public safety undermining the health and lives of American citizens. The world witnessed the consequences of those irresponsible policies: namely, a colossal break down in the nation’s homeland security…
Testimony by Vera Hassner Sharav, President ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Hearing of the NYS Assembly Committee on Health and Committee on Children and Families September 8, 2005 New York City I speak on behalf of the ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP), the organization that filed the…
EPA Declines to Show Proposed Regulations for Human Pesticide Experiments Wed, 7 Sep 2005 When the committee of the Institute of Medicine gave the pesticide industry and the EPA the green light to accept data from human pesticide experiments, it opened the door for government-sanctioned experimental abuse that surpasses the…
Olive Oil Better than Anti-Inflammatory Drugs Tue, 6 Sep 2005 Amidst the disaster, one ray of good news for universal good health! This news was burried in a side bar of the Science section of The New York Times. Contact: Vera Hassner Sharav 212-595-8974 The New York Times September 6,…
Joint Commission on Accreditation of Healthcare Orgs & NCQA Fri, 9 Sep 2005 After much hand wringing following public disclosrure that the current IRB (institutional review board) research review and approval process is so inadequate and unreliable, the (then) outgoing Secretary of Health and Human Services, Donna Shalala, acknowledged in…
John H. Noble, Jr., Ph.D. John H. Noble, Jr., Ph.D., retired in August, 2005, from his position as Endowed Professor for Social Justice, The Catholic University of America. He has been Professor Emeritus since 1993 at the State University of New York at Buffalo, where he held joint appointments in…
Johnson & Johnson stung by its own Advisory Committee–Natrecor should be strictly limited Fri, 12 Aug 2005 Kudos go to Dr. Eugene Braunwald and the 10 members of the advisory committee that he heads. Contrary to Johnson & Johnson expectations, the committee recommended extensive warnings to physicians against prescribing Natrecor…
New Diabetes Drug Increases Mortality / Morbidity – FDA “approvable” letter Challenged Fri, 21 Oct 2005 Today’s newspaper reports about a lethal new diabetes drug that the FDA was poised to approve makes abundantly clear that The New York Times got it wrong when it gave the FDA high marks…
Russian Roulette Medicine: More kids get multiple psychiatric drugs Wed, 3 Aug 2005 Stop the madness! Child psychiatrist, Joseph Penn, advises: “Parents shouldn’t passively accept whatever doctors recommend for children with behavior or psychiatric problems.” “We just don’t have the efficacy or safety data to back up what is common…
College Students Abuse of psychostimulants–Adderall / concerta / Ritalin Fri, 5 Aug 2005 The abuse of Ritalin and other prescribed amphetamine-like psychostimulant drugs by college students is spiralling as students have grown accustomed to rely on pills as a crutch for coping with pressure. Andrew Jacobs of the New York…
Applause to Editor of Amer J of Hypertension Who Said NO to financially compromised Society Fri, 29 Jul 2005 The Wall Street Journal reports: “In a dispute reflecting heightened concerns about the control and credibility of medical information, the American Society of Hypertension said it is severing its 16-year relationship…
